BACKGROUND: The Mini-Mental State Examination (MMSE) and the Montreal Cognitive Assessment (MoCA) are brief cognitive screening tools that have been developed for the screening of @entity1 with Mild @entity73 . METHODS: A total of 105 @entity1 were included in this study, aged 53-89  years, with acute @entity385 admitted to hospital and fell into two groups: @entity64 @entity1 with @entity73 (SCI) and controls with no @entity73 (n-SCI). The @entity1 's characteristics are collected and regression analyses were performed to predict @entity73 . We use MMSE and MoCA assessment as prognostic indices for @entity73 of @entity1 's with @entity64 . OBJECTIVES: Our aim was to examine the effectiveness of the MMSE and MoCA in screening @entity73 . MAIN RESULTS: There were significant difference among the two groups in the prevalence of @entity6 (p < 0.05) and @entity4522 (p < 0.05). A linear regression determined that the age, @entity6 , @entity4522 predicted the @entity73 . The ROC results for MoCA with an AUC of 0.882 and the corresponding results for MMSE show a similar AUC of 0.839. CONCLUSION: Neuropsychological performance of @entity64 @entity1 was influenced by biological and demographic variables: age, @entity6 and @entity4522 . The MoCA and MMSE are both reliable assessments for the diagnosis of @entity73 after @entity64 .

The use of MMSE and MoCA in @entity1 with acute XXXX in clinical.

@entity1 :: ('9606', 'Species') :: ['patients', 'patient'] @entity64 :: ('MESH:D020521', 'Disease') :: ['stroke'] @entity6 :: ('MESH:D003920', 'Disease') :: ['diabetes', 'diabetes mellitus'] @entity73 :: ('MESH:D003072', 'Disease') :: ['cognitive impairment', 'Cognitive Impairment', 'cognitive impairments'] @entity4522 :: ('MESH:D002537', 'Disease') :: ['intracranial atherosclerosis'] @entity385 :: ('MESH:D002544', 'Disease') :: ['ischemic stroke']
@entity385 :: (MESH:D002544,Disease) :: ['ischemic stroke']
